- MSc & BSc University College London
- Previously CEO of DRS-Commodities
Interests: Rugby, Cross Fit, Sports Tech
- US drug development company focused on Type II Diabetes.
- Australian Biotech developing a new class of anxiety drug.
- Asian gene therapy company focused on muscular dystrophy.
- German Bundesliga football team seeking an acquisition partner.
- US E&P developing unconventional Oil & Gas resources.
- MSc Stanford Business School
- Previously Associate at DRS-Commodities
- Member of the Worshipful Company of International Bankers
- European pharmaceutical company developing targeted anti-Cancer drugs.
- Canadian Biopharmaceutical company targeting treatments for Autoinflammatory Orphan Disease.
- US therapeutics player creating treatments for muscular diseases.
- Leading British Rugby team seeking stadium financing.
- Canadian Oil & Gas developer building a large, low-decline, liquids-focused asset base.
Interests: Hockey, Antique restoration
Guy Newman Allen
- MSc INSEAD
- Previously Associate Partner at DRS-Commodities
- Member of the British Venture Capital Association
- Australian oncology company pioneering a new therapy for solid tumor cancers.
- European pharma company focused on memory and cognition disorders trialling in Alzheimers.
- US med tech developing hand-held diagnostic devices for head injury and stroke assessment.
- English Premier league football team seekingan equity partner.
- ASX listed international explorer developing acreage in the Caribbean.
Interests: Creative writing, Ultra marathons